Marshall Wace
COCH icon

Marshall Wace’s Envoy Medical COCH Stock Holding History

Marshall Wace’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,080,871
Closed -$21M – 2721
2022
Q4 		$21M Hold
2,080,871
– – 0.05% 438
2022
Q3 		$20.5M Hold
2,080,871
– – 0.04% 455
2022
Q2 		$20.4M Hold
2,080,871
– – 0.04% 456
2022
Q1 		$20.3M Hold
2,080,871
– – 0.04% 489
2021
Q4 		$20.3M Buy
2,080,871
+339,999
+20% +$3.32M 0.04% 483
2021
Q3 		$16.9M Buy
1,740,872
+500,000
+40% +$4.84M 0.07% 327
2021
Q2 		$12M Buy
+1,240,872
New +$12.1M 0.05% 398

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Marshall Wace's COCH Position: Q1 2023 in Review

Marshall Wace sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 2,080,871 shares — an estimated $21M sold.

Marshall Wace first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $21M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Marshall Wace reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Marshall Wace sold 2,080,871 Envoy Medical shares in Q1 2023, an estimated $21M.
  • Marshall Wace first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Marshall Wace's Envoy Medical position peaked at $21M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.